Penumbra, Inc. (PEN) vs Insulet Corporation (PODD)
Penumbra, Inc. and Insulet Corporation are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.6B against $9.6B — 1.3× the size. Insulet Corporation trades at the lower P/E: 25.4× against 78.0×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 17.6%. Insulet Corporation has the higher net margin (12.3% vs 10.7%) and the higher return on invested capital (17.6% vs 13.1%). Across the 22 metrics below, Insulet Corporation leads on 17 and Penumbra, Inc. on 5.
Valuation
Profitability
| Metric | PEN | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 67.84% | 71.07% | 56.01% |
| Operating margin | 12.45% | 16.89% | (15.03%) |
| Net margin | 10.67% | 12.29% | (20.40%) |
| Free cash flow margin | 14.35% | 8.70% | (7.24%) |
| Return on equity | 11.37% | 26.02% | (15.32%) |
| Return on assets | 8.80% | 11.31% | (19.72%) |
| Return on invested capital | 13.13% | 17.56% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack